Jennifer Quinn
Global Head of Value and Access, Debiopharm International SA
Throughout her career, Jennifer has specialised in global market access and value demonstration. Having spent many years working in the rare disease space, she is familiar with challenging pricing and reimbursement negotiations. Since joining Debiopharm as the Global Head of Value and Access, she has been working to generate strong value evidence that demonstrates the burden of illness and benefit of treatment in AMR, whilst considering additional pathways for reimbursement of new antibiotics (on top of subscription models).